Screener
Vera Therapeutics VERA Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Vera Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212143
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current liabilities | 45,149 | 53,455 |
| Long-term debt | 75,029 | 74,838 |
| Other liabilities, noncurrent | 1,864 | 1,919 |
| Total liabilities | 122,042 | 130,212 |
| Stockholders’ equity | ||
| Class A common stock, $0.001 par value; 500,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 71,730,090 and 71,267,429 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 72 | 71 |
| Additional paid-in capital | 1,381,678 | 1,364,529 |
| Accumulated other comprehensive (loss) income | (156) | 786 |
Item 1. Financial Statements
FAQ
- What is Vera Therapeutics's total liabilities?
- Vera Therapeutics (VERA) reported total liabilities of $122.04M in Q1 2026.
- How has Vera Therapeutics's total liabilities changed year-over-year?
- Vera Therapeutics's total liabilities increased by 62.4% year-over-year, from $75.17M to $122.04M.
- What is the long-term trend for Vera Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Vera Therapeutics's total liabilities has grown at a 97.6% compound annual growth rate (CAGR), from $4.33M to $130.21M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Vera Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude